GE HealthCare Technologies Inc. (NASDAQ:GEHC) Plans Quarterly Dividend of $0.04

GE HealthCare Technologies Inc. (NASDAQ:GEHC) announced a quarterly dividend on Thursday, November 21st,Wall Street Journal reports. Stockholders of record on Tuesday, January 14th will be paid a dividend of 0.035 per share on Friday, February 14th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.17%. The ex-dividend date of this dividend is Tuesday, January 14th. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.03.

GE HealthCare Technologies has a payout ratio of 2.7% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect GE HealthCare Technologies to earn $4.67 per share next year, which means the company should continue to be able to cover its $0.14 annual dividend with an expected future payout ratio of 3.0%.

GE HealthCare Technologies Trading Down 1.7 %

Shares of NASDAQ:GEHC opened at $84.76 on Friday. The company has a market capitalization of $38.72 billion, a PE ratio of 23.29, a PEG ratio of 2.90 and a beta of 1.11. GE HealthCare Technologies has a 12-month low of $71.31 and a 12-month high of $94.55. The business has a 50 day moving average of $82.25 and a two-hundred day moving average of $84.13. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, beating the consensus estimate of $1.06 by $0.08. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The company had revenue of $4.86 billion for the quarter, compared to analyst estimates of $4.87 billion. During the same quarter last year, the business earned $0.99 earnings per share. The firm’s revenue was up .9% on a year-over-year basis. As a group, analysts forecast that GE HealthCare Technologies will post 4.3 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the company. Wells Fargo & Company upped their price target on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a report on Thursday, October 31st. Evercore ISI increased their target price on GE HealthCare Technologies from $98.00 to $102.00 and gave the company an “outperform” rating in a research report on Tuesday, October 1st. Stifel Nicolaus boosted their price target on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a “buy” rating in a report on Monday, September 30th. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their target price for the company from $95.00 to $103.00 in a research report on Wednesday. Finally, BTIG Research upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price objective on the stock in a report on Wednesday, September 18th. One analyst has rated the stock with a sell rating, four have issued a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and a consensus price target of $96.00.

Insider Activity at GE HealthCare Technologies

In related news, CEO Roland Rott sold 3,577 shares of the business’s stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total value of $309,338.96. Following the sale, the chief executive officer now directly owns 24,298 shares in the company, valued at approximately $2,101,291.04. The trade was a 12.83 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.27% of the stock is currently owned by insiders.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.